20273 results for «»
20273 results
Ronney Shantouf
Abu Dhabi, United Arab Emirates
Richa Sharma
Uttarakhand, India
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Haitham Sholy
Kabul, Israel
Juwairia Alali
Dubai, United Arab Emirates
Showjad Panikkaveettil Thekkarayil
Thrissur, India
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
08 Nov 2022
Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.
Author
Sudarshan Kumar Vijay
Uttar Pradesh, India
Mehmood Zeb
Dubai, United Arab Emirates
Saleh Alshalash
Riyadh, Saudi Arabia
Impella utilization in high-risk percutaneous coronary intervention (last remaining vessel)
01 Dec 2022
From a clean puncture to a safe utilization of Impella in high-risk PCI.
Author
Author
First half of DK-Crush technique for bailout stenting of a true 0,0,1 bifurcation
09 Dec 2022
Stent implantation is largely debated in true 0,0,1 bifurcation lesion. This case shows bailout IVUS-guided stenting of a large diagonal branch after DEB-induced dissection, performed by employing the first half of the DK-Crush technique, thus avoiding stenting in the disease-free left anterior descending artery.
Author
Author
Author
What are the remaining limitations of TAVI?
07 Jun 2018
View thereplay of this webinar on TAVI with N. Dumonteil, A. S. Petronio and D. Blackman.
Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study
14 Aug 2022
The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.
Reviewer
PCR Webinars on Coronary Interventions
16 Aug 2022
PFO closure in 2019 – Who, Why and How?
20 Jul 2022
View this replay of a LIVE Round Table Webinar - PFO closure in 2019 – Who, Why and How?, with P. Calvert, C. Grasso and P. Lurz
Structural Heart Disease pre-procedural sizing and planning tutorials: TAVR / TAVI
17 Aug 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-procedural sizing and planning in TAVR, Valve-in-Valve, re-do TAVR, alternate access and more.
Bifurcation continuum 2021: the journey continues
17 Aug 2022
Bifurcation continuum 2020
17 Aug 2022
Bifurcation continuum 2019
17 Aug 2022